SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-004605
Filing Date
2020-02-13
Accepted
2020-02-13 16:23:30
Documents
64
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnov-10k_20191231.htm 10-K 1855683
2 EX-23.1 mnov-ex231_7.htm EX-23.1 2929
3 EX-31.1 mnov-ex311_6.htm EX-31.1 8473
4 EX-31.2 mnov-ex312_10.htm EX-31.2 8538
5 EX-32.1 mnov-ex321_8.htm EX-32.1 6735
6 EX-32.2 mnov-ex322_9.htm EX-32.2 7393
  Complete submission text file 0001564590-20-004605.txt   5936790

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnov-20191231.xml EX-101.INS 1098004
8 XBRL TAXONOMY EXTENSION SCHEMA mnov-20191231.xsd EX-101.SCH 43650
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20191231_cal.xml EX-101.CAL 57084
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20191231_def.xml EX-101.DEF 127546
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20191231_lab.xml EX-101.LAB 389640
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20191231_pre.xml EX-101.PRE 292677
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 20610924
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences